This article argues that the public is misled regarding mammography screening, particularly in relation to three key claims: that it saves lives, reduces the need for invasive surgeries, and detects cancer at an early stage. Evidence presented indicates that mammography does not reduce overall mortality rates, with randomized trials showing no significant difference in death rates between those who undergo screening and those who do not. Further, breast cancer mortality as an outcome measure is criticized for being biased due to methodological flaws in trial assessments. The author highlights the issue of overdiagnosis, stating that many detected cancers would not progress or pose a threat, leading to unnecessary treatments. It is asserted that screening may actually increase mastectomies due to the rise in detected cases, contradicting claims that it leads to less invasive surgeries. The article concludes with a call for ethical considerations in informed consent, suggesting that women should be cautious of misleading practices surrounding screening invitations, implying systemic deceit in promoting mammography screening despite its harmful effects.